Citius Oncology, Inc. - Common Stock

Share · US17331Y1091 · CTOR (XNAS)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

16.12.2025 20:59

Current Prices from Citius Oncology, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	CTOR	USD	16.12.2025 20:59	1,09 USD	0,03 USD +2,35 %

Share Float & Liquidity

Free Float 5,39 %

Shares Float 4,57 M

Shares Outstanding 84,8 M

Company Profile for Citius Oncology, Inc. - Common Stock Share

Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York. Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.

Get up to date insights from finAgent about Citius Oncology, Inc. - Common Stock

Company Data

Name Citius Oncology, Inc. - Common Stock

Company Citius Oncology, Inc.

Symbol CTOR

Primary Exchange

NASDAQ

ISIN US17331Y1091

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - General

CEO Leonard L. Mazur

Market Capitalization 91 Mio

Country United States of America

Currency USD

Employees -

Address 420 Lexington Avenue, 10170 New York City

ID Changes

Date	From	To
13.08.2024	TENK	CTOR

Ticker Symbols

Name	Symbol
NASDAQ	CTOR

More Shares

Investors who hold Citius Oncology, Inc. - Common Stock also have the following shares in their portfolio:

NOVONIX LTD SP.ADS/4 Depository Receipt

The RBB Fund, Inc. SGI U.S. Large Cap Core ETF ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog